
Private equity · Growth stage
108 BioCapital
An American private equity fund focused on growth-stage biotech and medtech companies tackling serious clinical gaps, led by a biotechnologist founder.
Investment activity
Round-by-round activity is part of PRO
Key signal this week
Is 108 BioCapital right for your round?
Key stats
Fund cycle Public record
Fund vehicles on public registers (SEC adviser filings). Values are the gross assets each filing reports, not fund sizes.
Latest investments
Rounds 108 BioCapital joined, from press and the firm’s own posts.
Every round 108 BioCapital joined
Round sizes, 108 BioCapital’s role and who invested alongside.
Where the money goes
Share of companies at first investment, from the rounds we track.
Investment team
Where to meet 108 BioCapital
Events where 108 BioCapital’s team spoke or showed up, from event programmes, press and the firm’s own posts.
Signals
Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.
Founders also look at
Frequently asked questions
108 BioCapital is based in Danbury, United States.
2 fund vehicles are on public registers (SEC adviser filings), including 108 BIOCAPITAL GROWTH FUND, LP and 108 BIO PINWHEEL CO-INVESTMENT, LLC.
Stages: Growth. Sectors: Biotech, Medtech. From the firm’s own website.
Backs transformative healthcare ventures, with particular interest in medical devices for diagnosis and treatment as well as tailored medicine, that target serious clinical gaps and improve patient outcomes. It sees rising US healthcare spending as the opportunity and works with entrepreneurs and management teams, applying its expertise and network to speed growth. From the firm’s own website.
Know before 108 BioCapital’s next round is announced.
PRO tracks 108 BioCapital’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.